Back to search
Restenosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Restenosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Restenosis trials you may qualify forThe purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up…
The study objectives are: 1. To evaluate the safety and performance of the SirPlux Duo PTCA to treat coronary ISR lesions 2.00-4.00 mm (inclusive) in diameter…
Percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) accounts for 5-10% of PCI. ISR may be linked to mechanical complications mainly under-exp…
This study aimed to compare the clinical and angiographic outcomes of patients with DES-ISR who underwent repeat PCI with intravascular imaging or angiographic…
This is a self-controlled cohort study to evaluate the efficacy and safety of comprehensive treatment in patients with inflammation-associated rapidly-progressi…
The goal of this observational study is to gather additional safety and performance (effectiveness) data on the device for the treatment of symptomatic lower ex…
This randomized, double-blind, controlled clinical trial will evaluate the effects of daily supplementation with functionalized bovine milk, enriched with bioac…